ArticleBMC medical informatics and decision making2025
Multiclass skin lesion classification and localziation from dermoscopic images using a novel network-level fused deep architecture and explainable artificial intelligence.
Article in BMC medical informatics and decision making, 2025. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 5 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
5 citing papers in PubMed.
- Artificial intelligence with deep learning driven entropy-curvature attention mechanism for detection and segmentation of skin lesions using biomedical images.Scientific reports · 2026Article
- CBAM-Xception: An Attention-Guided Framework for Skin Cancer Classification.Journal of imaging informatics in medicine · 2026Article
- Hypergraph-based contrastive embedding and attention fusion for detection of skin cancer.Scientific reports · 2026Article
- AI-assisted image analysis ofBioinformation · 2026Article
- Artificial intelligence in modern clinical practice (Review).Medicine internationalReview
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
BACKGROUND AND
objectiveEarly detection and classification of skin cancer are critical for improving patient outcomes. Dermoscopic image analysis using Computer-Aided Diagnostics (CAD) is a powerful tool to assist dermatologists in identifying and classifying skin lesions. Traditional machine learning models require extensive feature engineering, which is time-consuming and less effective in handling complex data like skin lesions. This study proposes a deep learning-based network-level fusion architecture that integrates multiple deep models to enhance the classification and localization of skin lesions in dermoscopic images. The goal is to address challenges like irregular lesion shapes, inter-class similarities, and class imbalances while providing explainability through artificial intelligence.
methodsA novel hybrid contrast enhancement technique was applied for pre-processing and dataset augmentation. Two deep learning models, a 5-block inverted residual network and a 6-block inverted bottleneck network, were designed and fused at the network level using a depth concatenation approach. The models were trained using Bayesian optimization for hyperparameter tuning. Feature extraction was performed with a global average pooling layer, and shallow neural networks were used for final classification. Explainable AI techniques, including LIME, were used to interpret model predictions and localize lesion regions. Experiments were conducted on two publicly available datasets, HAM10000 and ISIC2018, which were split into training and testing sets.
resultsThe proposed fused architecture achieved high classification accuracy, with results of 91.3% and 90.7% on the HAM10000 and ISIC2018 datasets, respectively. Sensitivity, precision, and F1-scores were significantly improved after data augmentation, with precision rates of up to 90.91%. The explainable AI component effectively localized lesion areas with high confidence, enhancing the model's interpretability.
conclusionsThe network-level fusion architecture combined with explainable AI techniques significantly improved the classification and localization of skin lesions. The augmentation and contrast enhancement processes enhanced lesion visibility, while fusion of models optimized classification accuracy. This approach shows potential for implementation in CAD systems for skin cancer diagnosis, although future work is required to address the limitations of computational resource requirements and training time. CLINICAL TRAIL NUMBER: Not applicable.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.